z-logo
open-access-imgOpen Access
Efficacy and safety of radiofrequency ablation for treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials
Author(s) -
Hua Zhang,
Bo Wang,
Jie He,
Zhongju Du
Publication year - 2021
Publication title -
journal of international medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 57
eISSN - 1473-2300
pISSN - 0300-0605
DOI - 10.1177/03000605211006647
Subject(s) - medicine , radiofrequency ablation , osteoarthritis , meta analysis , placebo , randomized controlled trial , adverse effect , systematic review , physical therapy , medline , surgery , ablation , alternative medicine , pathology , political science , law
Objective To evaluate the efficacy and safety of radiofrequency ablation for the treatment of knee osteoarthritis.Methods A literature review was conducted using the PubMed, Cochrane Review, Embase, and Google Scholar databases. Two reviewers independently assessed the eligibility of all retrieved studies. The research was reported based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to ensure the reliability and verity of the results. The statistical analysis was performed using STATA version 13.0.Results Nine randomized controlled trials were collected for the data extraction and meta-analysis. Significant differences in the pain score at 4, 12, and 24 weeks were found between patients treated with radiofrequency ablation and those treated with placebo. Furthermore, the use of radiofrequency ablation was associated with an improved outcome of the Western Ontario and McMaster Universities Arthritis Index at 4, 12, and 24 weeks. No serious adverse events were observed in any patients who underwent radiofrequency ablation.Conclusion Radiofrequency ablation is efficacious and safe for reducing pain and improving knee function in patients with knee osteoarthritis, without increasing the risk of adverse effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here